Loading company
$0.38-2.2%Nov 13 close
Next earnings: December 18, 2026
Figures through June 30, 2026, from the 10-Q filed August 13, 2026
Past performance
- 1W
- -7.9%
- 1M
- +8.5%
- 3M
- -22.7%
- 6M
- -52.7%
- 1Y
- -40.3%
- 5Y
- -99.9%
$0.38-2.2%Nov 13 close
Next earnings: December 18, 2026
Figures through June 30, 2026, from the 10-Q filed August 13, 2026
cbdMD, Inc. is scheduled to report next on December 18, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $5.6M | $4.6M | +20.56% |
| Profit | -$1.1M | -$895.3K | -25.91% |
| Free Cash Flow | -$460.2K | -$705.7K | +34.78% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
cbdMD, Inc. has no earnings call transcript available.
Releases land before the open or after the close, so the window runs from the close before the report day to the close of the session after it — the reaction is inside it either way.
Results The preliminary unaudited financial results presented in this release are preliminary and may change. The preliminary unaudited financial information includes calculations or figures that have been prepared internally by management and have not been reviewed or audited by our independent registered public accounting firm. There can be no assurance that cbdMD, Inc.'s actual results for the periods presented herein will not differ from the preliminary unaudited financial data presented herein, and such changes could be material. This preliminary unaudited financial data should not be viewed as a substitute for full audited consolidated financial statements prepared in accordance with GAAP and is not necessarily indicative of the results to be achieved for any future period. Our audited consolidated financial statements for the fiscal year ended September 30, 2025 will be contained in our Annual Report on Form 10-K to be filed with the Securities and Exchange Commission on or before December 29, 2025.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from cbdMD, Inc.’s Item 2.02 8-K filed November 25, 2025; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.